中国学者近期发表的论文
1.	RARγ-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen. Author: Zhang X1,2,3, Li F1,2,3, Wang J1,2,3, Suo S1,2,3, Ling Q1,2,3, Yu W1,2,3, Jin J1,2,3. Journal: Leuk Lymphoma. 2019 Jan 11:1-4. doi: 10.1080/10428194.2018.1553302. [Epub ahead of print]    PubMed      DOI
2.	Targeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma. Author: Cai K1, Na W1, Guo M2, Xu R1, Wang X1, Qin Y1, Wu Y1, Jiang J1, Huang H1. Journal: Leuk Lymphoma. 2019 Mar;60(3):772-781. doi: 10.1080/10428194.2018.1493727. Epub 2019 Jan 15.    PubMed      DOI
3.	Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group. Author: Chen SH1, Chen JS2, Jou ST3, Wu KH4, Hung IJ1, Sheen JM5, Lu MY3, Chen BW6, Jaing TH1, Wang SC7, Lin MT7, Chang TK8, Liu HC9, Yang CP1. Journal: Leuk Lymphoma. 2019 Jan 15:1-8. doi: 10.1080/10428194.2018.1562182. [Epub ahead of print]    PubMed      DOI
4.	Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol. Author: Wang XX1,2, Li PF1,2, Bai B1,2, Gao Y1,2, Rong QX1,2, Cai QQ1,2, Lin SX1,3, Zhang YJ1,4, Li ZM1,2, Jiang WQ1,2, Huang HQ1,2. Journal: Leuk Lymphoma. 2019 Jan 16:1-9. doi: 10.1080/10428194.2018.1563690. [Epub ahead of print]    PubMed      DOI
5.	Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases. Author: Zhang J1, Yang F1, Qiu HY1, Wu Q1, Kong DQ1, Zhou J1, Han Y1, Wu DP1. Journal: Leuk Lymphoma. 2019 Feb 4:1-8. doi: 10.1080/10428194.2018.1533127. [Epub ahead of print]    PubMed      DOI
6.	Suppression of minichromosome maintenance 7 expression sensitizes chronic lymphocytic leukemia cells to fludarabine. Author: Xu Y1, Zhou X1, Li Y1, Zhang Y1, Wang X1,2. Journal: Leuk Lymphoma. 2019 May;60(5):1266-1274. doi: 10.1080/10428194.2018.1523400. Epub 2019 Feb 4.    PubMed      DOI
7.	Plasma fibrinogen levels correlate with prognosis and treatment outcome in patients with non-M3 acute myeloid leukemia. Author: Dai K1, Zhang Q1, Li Y1,2, Wu L1, Zhang S1,3, Yu K1. Journal: Leuk Lymphoma. 2019 Feb 8:1-9. doi: 10.1080/10428194.2018.1535116. [Epub ahead of print]    PubMed      DOI
8.	Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations. Author: Deng DX1, Zhu HH1, Liu YR1, Chang YJ1, Ruan GR1, Jia JS1, Jiang H1, Jiang Q1, Zhao XS1, Huang XJ1,2. Journal: Leuk Lymphoma. 2019 Feb 18:1-9. doi: 10.1080/10428194.2019.1576868. [Epub ahead of print]    PubMed      DOI
9.	Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. Author: Horvath N1, Spencer A2, Kenealy M3, Joshua D4, Campbell PJ5, Lee JJ6, Hou J7, Qiu L8, Kalff A2, Khong T2, Londhe A9, Siggins S10, van Kooten Losio M10, Eisbacher M10, Prince HM3,11. Journal: Leuk Lymphoma. 2019 Feb 19:1-12. doi: 10.1080/10428194.2019.1579322. [Epub ahead of print]    PubMed      DOI
10.	Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia. Author: Luo X1, Chen S1, Zhang J2, Ren J1, Chen M1, Lin K1, Zhu H1, Zheng R1, Zheng Z1, Chen Z1, Hu J1, Yang T1. Journal: Leuk Lymphoma. 2019 Feb 26:1-8. doi: 10.1080/10428194.2019.1581928. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore BLOOD 426 18.60 Journal of Hematology & Oncology 60 15.20 LEUKEMIA 176 14.70 AMERICAN JOURNAL OF HEMATOLOGY 92 9.20 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 111 10.10 BLOOD REVIEWS 85 10.70 BRITISH JOURNAL OF HAEMATOLOGY 172 8.10 SEMINARS IN HEMATOLOGY 88 7.10 TRANSFUSION MEDICINE REVIEWS 65 7.40 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 74 5.60

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 301668 CANCER RESEARCH 166473 Molecular Medicine Reports 165309 International Journal of Nanomedicine 164985 CANCER LETTERS 160117 JOURNAL OF ETHNOPHARMACOLOGY 142368 BIOMEDICINE & PHARMACOTHERAPY 141587 Theranostics 136618 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 136490 International Journal of Environmental Research and Public Health 134176